(Q33778807)

29 July 2017

1 reference

title

Review article: pharmacological options in achalasia (English)

1 reference

29 July 2017

1 reference

Bassotti G

1

1 reference

29 July 2017

Annese V

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Alimentary Pharmacology & Therapeutics

29 July 2017

published in

1 reference

29 July 2017

volume

13

1 reference

29 July 2017

issue

11

1 reference

29 July 2017

page(s)

1391-1396

1 reference

Achalasia: what's new in diagnosis and treatment?

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Family occurrence of achalasia and diffuse spasm of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Are human herpes viruses or measles virus associated with esophageal achalasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

An Uncontrolled Comparison of Treatments For Achalasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Effect of nitrates on LOS pressure in achalasia: a potential therapeutic aid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Current medical therapy for esophageal motility disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

An overview of the role of calcium antagonists in the treatment of achalasia and diffuse oesophageal spasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Current therapies for achalasia: comparison and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Intrasphincteric botulinum toxin for the treatment of achalasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Botulinum toxin for achalasia: long-term outcome and predictors of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

Laparoscopic Heller myotomy and fundoplication for achalasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00645.X

10.1046/J.1365-2036.1999.00645.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference